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Introduction: Cavernous hemangiomas are common benign tumors of the skin or liver but can also rarely
originate from the retroperitoneal space, especially adjacent to the renal hilum. Qualitative characterization of these
retroperitoneal tumors using available imaging modalities is relatively difficult.
Case presentation: A 40-year-old Japanese woman was incidentally noted to have a round homogenous tumor
adjacent to the left renal hilum on computed tomography. The preoperative diagnosis was paraganglioma
according to hormonal and clinical findings. The tumor was successfully resected via a laparoscopic approach,
and histopathological examination of the tumor revealed cavernous hemangioma.
Conclusions: Cavernous hemangioma is a rare but relatively benign disease when considering the different types
of retroperitoneal tumors. We were able to effectively treat the retroperitoneal cavernous hemangioma via
laparoscopy.
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Retroperitoneal neoplasms are relatively rare, but
widespread use of sophisticated imaging studies has
resulted in an increase in the number of cases of
retroperitoneal neoplasms that are detected. Among
retroperitoneal tumors, cavernous hemangioma (CH)
is even rarer [1,2]. Since the pathological features of
retroperitoneal tumor are often difficult to diagnose
on various imaging modalities, the operative approach
is often the only practical treatment strategy. The
methods of operative treatment may be one of the im-
portant discussion points due to various anatomical
features of tumors, that is, tumor size and location.
The present report describes a case of a patient with a
cavernous hemangioma adjacent to the left renal
hilum. This tumor was successfully resected using a
laparoscopic approach.* Correspondence: tigawa@nagasaki-u.ac.jp
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A 40-year-old Japanese woman was referred to our de-
partment due to a retroperitoneal tumor. Originally, she
planned to undergo surgical repair of an umbilical her-
nia, but pre-operative evaluation by computed tomog-
raphy (CT) revealed a round-shaped solid mass,
4×3×3cm in size, located in the retroperitoneum just
below the left renal vein. The tumor was gradually
and weakly enhanced beginning in its peripheral area
(Figure 1). Magnetic resonance imaging (MRI) showed a
tumor with low signal intensity on T1-weighted images
and very high signal intensity on T2-weighted images
(Figure 2). Our patient had been undergoing antihyper-
tensive treatment for three years and complained of
a mild headache at the time of consultation; therefore,
we first suspected paraganglioma. A hormonal study and
123I-metaiodobenzylguanidine (MIBG) scintigraphy were
performed, showing an elevated plasma norepinephrine
level (702pg/ml; normal range, 100 to 450pg/ml) and
a normal plasma epinephrine (32pg/ml; normal range,
<100pg/ml) and dopamine (10pg/ml; normal range,
<20pg/ml) level. A 24-hour urine collection demon-
strated a slight increase in normetanephrine leveltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Abdominal computed tomography findings. Plain computed tomography showed a homogenous round tumor of 4×3×2cm in size
(A) and weak enhancement in the peripheral area of the tumor (B).
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123I-metaiodobenzylguanidine (MIBG) scintigraphy did
not show high uptake in the tumor area. Based on these
results, we could not completely rule out paragan-
glioma, and our patient was started on doxazosin (2mg
daily, with stepwise dose-escalation to a maximum dose
of 14mg daily).
Next, surgical removal of the tumor was performed. Our
patient was placed in a modified lateral decubitus position
(approximately 60 degrees) and underwent surgery via the
transperitoneal approach using three ports and standard
laparoscopic devices under general anesthesia. No severe
adhesion was observed during the surgical procedure, and
the tumor was radically resected in 1.5 hours, with an
estimated blood loss of 5ml. The cut surface of the tumor
appeared dark brick-colored and had a homogenous
macroscopic appearance (Figure 3A). Histopathological
examination revealed poorly circumscribed and irregularly
dilated blood vessels filled with red blood cells, and the
blood vessels were lined by a flat endothelium (Figure 3B).
A diagnosis of cavernous hemangioma was made. Postop-
erative blood pressure and plasma catecholamine levels
were similar to that observed before the operation. OurFigure 2 Magnetic resonance imaging findings. (A) T1-weighted image
intensity on T2-weighted images.patient has not experienced any recurrence over the two-
year follow-up period.
Discussion
CH most commonly affects the skin, mucosa and liver
but can rarely occur in the retroperitoneal space. Several
reports of CH originating from retroperitoneal organs
(for example, adrenal gland, kidney and pancreas) are
available, but primary retroperitoneal CH is even rarer
[1,2]. CH is essentially a benign neoplasm that produces
clinical symptoms only when the tumor compresses an
adjacent organ or tissue. Most reported cases of retro-
peritoneal CH involve symptoms of abdominal pain
when the tumor grows to a large size (for example, ap-
proximately 10cm in diameter). However, most cases of
CH are asymptomatic and are only incidentally detected
on routine imaging, as occurred in our present case. Based
on the tumor location, MRI findings and abnormal cat-
echolamine studies in our present case, we could not rule
out paraganglioma and elected to utilize surgical resection
as the treatment strategy. In regard to imaging findings,
our present case showed relatively slow and weak en-
hancement on CT imaging, and enhancement was patchys showed a tumor with low signal intensity and (B) very high signal
AB
Figure 3 Macroscopic findings and histopathology of the resected specimens. (A) The tumor was capsulized and was dark brick in color.
(B) Microscopic examination of the specimen showed dilated and congested vascular spaces lined by a single layer of endothelial cells,
hematoxylin and eosin (HE) staining × 40.
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ganglioma. This observation may be a diagnostic feature
that is specific to retroperitoneal CH and could be used to
differentiate retroperitoneal CH from paraganglioma.
However, the CT findings of retroperitoneal CH have not
been extensively characterized [3,4]. Further, CT findings
of CH may differ depending on the organ of origin. For
example, typical CH of the pancreas shows strong contrast
enhancement when compared with that of normal pan-
creas tissue [5]. He et al. described a well-encapsulated
retroperitoneal CH without enhancement of the inner
component [2]. Similar to CT, MRI findings of retroperi-
toneal CH have not been well established. In general, CH
shows low signal intensity on T1-weighted images and
relatively high signal intensity on T2-weighted images.
However, the degree of signal intensity might vary de-
pending on the specific tumor component. Despite the
availability of various imaging modalities, the differential
diagnosis of retroperitoneal tumors adjacent to renal
hilum still includes neurogenic tumors (for example, neu-
roganglioma, schwannoma), and lymphangiogenic tumors,
(for example, lymphoma, IgG4-related disease), and other
rare soft tissue tumors (for example, sarcomas). Thus, ac-
curate pre-treatment diagnosis of retroperitoneal tumors
remains difficult [6].
Usually, watchful waiting is a common treatment strat-
egy for asymptomatic and small CHs. In fact, hepatic
CH is treated only when the tumor is large or produces
symptoms. However, Forbes reported spontaneous rup-
ture of adrenal hemangioma, which manifested as severe
pain and hypotension [7]. Further, Takeda et al. reported
rapidly growing CH with continuous abdominal pain [8].
In addition, as in our present case, a diagnosis of para-
ganglioma or other malignant tumors is often difficult to
exclude. These observations indicate that routine follow-
up and adequate therapeutic intervention are sometimesrequired even for small retroperitoneal CHs. As for the
therapeutic intervention, surgical resection could be the
only and most effective treatment for retroperitoneal tu-
mors at the moment. Other treatment modalities, for ex-
ample, kinds of molecular targeted therapy, chemotherapy
or radiation therapy, are tentatively applied for a small
portion of cases.
In our present case, the laparoscopic approach was
utilized for tumor resection. Since the tumor was located
close to large vessels, (that is, left renal hilar vessels and
abdominal aorta), meticulous manipulation was required
and surgical resection might be challenging for this type
of tumor. However, a laparoscopic procedure under
magnified view can be a reasonable and safe approach
when conducted by an experienced surgeon. In addition,
postoperative recovery is much faster after laparoscopic
resection when compared with recovery after open
laparotomy. However, unexpected tumor adhesion or in-
vasion can sometimes be appreciated during the laparo-
scopic approach, and these findings often necessitate
conversion to an open approach. Recent studies suggest
that laparoscopic resection is a safe and feasible opera-
tive approach for hemangioma of the adrenal gland or
for paraganglioma [9,10]. Thus, the laparoscopic ap-
proach might represent a new standard operative pro-
cedure for the surgical management of retroperitoneal
tumor. More precise preoperative diagnosis of retroperi-
toneal tumors would be of benefit to facilitate selection
of the optimal treatment strategy.
Conclusions
Our report describes a rare case of retroperitoneal CH ad-
jacent to the renal hilum that was difficult to distinguish
from paraganglioma based on the clinical findings. CH
should be considered within the differential diagnosis of
retroperitoneal tumors, and a patchy CT enhancement
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tive of a diagnosis of CH. The laparoscopic route represents
a feasible and safe surgical approach for these tumors.
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